Exploring the relationship of the zodiac, wearable tech and online dating!

Chicago
Joined September 2014
F2G looks for FDA new drug application approval for invasive fungal infections treatment  bit.ly/3PPLoSw
9
Mayo, CommonSpirit, Henry Ford Health: Where hospitals are spending their innovation dollars bit.ly/3VcAKWT
8
Overcome Genomics Benefits Management Vulnerabilities With Vetted Expertise bit.ly/3G6Pvq5
5
Mayo, CommonSpirit, Henry Ford Health: Where hospitals are spending their innovation dollars bit.ly/3VcAKWT
13
F2G looks for FDA new drug application approval for invasive fungal infections treatment  bit.ly/3PPLoSw
5
Overcome Genomics Benefits Management Vulnerabilities With Vetted Expertise bit.ly/3G6Pvq5
4
10 Reasons to Keep an Eye on Chicago Biotech in 2023 bit.ly/3srL9C8
10 Reasons to Keep an Eye on Chicago Biotech in 2023 bit.ly/3srL9C8
1
1
A bacterial drug delivery platform to enable the next generation of nucleic acid and gene editing therapies. #Biofuture2022 #biotechnology #geneediting #nucleicacid #drugmanufacturing @demycolton bit.ly/3T9wpDI
'It still prevented cancers': Experts discuss furor over colonoscopy study and dissect the nuances bit.ly/3gckQwT
Developing radiopharmaceutical imaging and therapies in areas of oncology. #Biofuture2022 #Biotechnology industries #clinical #radiopharmaceuticalimaging #oncology @demycolton $RAD bit.ly/3T9wpDI
The future for practicing physicians in a corporate world bit.ly/3Cy5TN2
Developing an improved pneumococcal conjugate vaccine (iPCV) that includes serotypes causing 95% of invasive pneumococcal disease. #Biofuture2022 #biotechnology #vaccine #pneumococcaldisease @demycolton bit.ly/3T9wpDI
Developing an improved pneumococcal conjugate vaccine (iPCV) that includes serotypes causing 95% of invasive pneumococcal disease. #Biofuture2022 #biotechnology #vaccine #pneumococcaldisease @demycolton bit.ly/3T9wpDI